Bill of Health
SEPTEMBER 12, 2023
By James René Jolin and Susannah Baruch On July 13, 2023, the United States Food and Drug Administration (FDA) approved Opill (norgestrel) as the first daily oral contraceptive available for non-prescription use in the U.S. James René Jolin (JRJ): This recent move by the FDA is one without precedent. It was a long time coming.
Healthcare IT Today
JANUARY 8, 2024
While each company successfully gained FDA approvals, the current market acceptance for prescription digital therapeutics is low and improvements will take years. They will continue to run clinical trials to confirm their claims and value proposition but will not seek FDA approvals. Dave Latshaw, CEO at BioPhy 1.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hall Render
FEBRUARY 18, 2022
Meet new FDA chief Dr. Robert Califf: 5 things to know. Outpatient push being felt in architecture industry. Colorado mental health professionals incensed after Medicaid forum that was intended to clear the air. Florida health system settles improper Medicaid payment allegations for $5.5M. MISSISSIPPI.
Healthcare IT Today
JANUARY 9, 2023
This could be a breakthrough for the pharmaceutical industry. Lauren Ohlsson, Lead of Industry Solutions – Pharmaceuticals & Healthcare at VDX.tv. In 2023, PLD (Physician Level Data) reporting from digital media partners will become increasingly essential to pharmaceutical organizations.
Hall Render
APRIL 21, 2023
health-tech startup MemoryWell pivots, eyes new funding to roll out software for insurers Department of Veterans Affairs health system kicks off multiyear Greater Washington expansion Georgetown to open Southeast D.C.
Expert insights. Personalized for you.
184 
Let's personalize your content